Merontos, Angelic H.

HRN: 22-47-45  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/17/2023
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
01/17/2023
01/23/2023
IV
4.5g
Q8H
Pelvic Infection
Waiting Final Action 

Indication:  Empiric    Type of Infection:  Intra-abdominal    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: